0001626370-25-000002.txt : 20250620 0001626370-25-000002.hdr.sgml : 20250620 20250620092418 ACCESSION NUMBER: 0001626370-25-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20250620 DATE AS OF CHANGE: 20250620 EFFECTIVENESS DATE: 20250620 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Inomagen Therapeutics, Inc. CENTRAL INDEX KEY: 0001626370 ORGANIZATION NAME: EIN: 472024034 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-549400 FILM NUMBER: 251059331 BUSINESS ADDRESS: STREET 1: 21 EAST HURON ST., #807 CITY: CHICAGO STATE: IL ZIP: 60611 BUSINESS PHONE: 312-961-8166 MAIL ADDRESS: STREET 1: 21 EAST HURON ST., #807 CITY: CHICAGO STATE: IL ZIP: 60611 FORMER COMPANY: FORMER CONFORMED NAME: Rhythm Therapeutics, Inc. DATE OF NAME CHANGE: 20141124 D 1 primary_doc.xml X0708 D LIVE 0001626370 Inomagen Therapeutics, Inc. 1375 W Fulton Street Ste 650 CHICAGO IL ILLINOIS 60607 312 805 8701 DELAWARE Rhythm Therapeutics, Inc. Corporation true Rishi Arora 1375 W Fulton Street Ste 650 Chicago IL ILLINOIS 60607 Executive Officer Director James R. Vogler 1375 W Fulton Street Ste 650 Chicago IL ILLINOIS 60607 Director Marc Penn 1375 W Fulton Street Ste 650 Chicago IL ILLINOIS 60607 Director Biotechnology Decline to Disclose 06c false 2025-06-05 false true false 0 3778984 140000 3638984 false 4 0 0 0 false Inomagen Therapeutics, Inc. /s/ Rishi Arora Rishi Arora, MD President and CEO 2025-06-19